“AI Based non-mydriatic fundus camera" with primary screening function for three major causes of blindness by predicting the risk of glaucoma, diabetic retinopathy and macular degeneration with traffic light signals within one second of fundus shooting.

bt_bb_section_bottom_section_coverage_image

“AI Based non-mydriatic fundus camera" with primary
screening function for three major causes of blindness
by predicting the risk of glaucoma, diabetic retinopathy
and macular degeneration with traffic light signals within
one second of fundus shooting.

Our Expertise

We supply digital medical imaging solutions to domestic university hospitals
and general hospitals in conjunction with operating rooms and outpatient medical imaging equipment.

http://umivision.co.kr/wp-content/uploads/2021/11/main_01.jpg

SLIT LAMP

http://umivision.co.kr/wp-content/uploads/2021/11/main_02.jpg

SLIT LAMP UPGRADE

http://umivision.co.kr/wp-content/uploads/2021/11/main_03.jpg

MEDICAPTURE

Ubiquitous Medical
Information

UMI Optics Co., Ltd. is a venture company which manufactures ophthalmic medical devices based on technology

Fundus cameras and polar microscopes are essential for diagnosing ophthalmic lesions. We Started with the development of digital interfaces that upgrade image of fundus cameras and polar microscopes into UHD level. UMI Optics has gained recognition in domestic and foreign hospitals, and expanded its business to the consumable market by producing its own eye treatment materials.

Certification Status

http://umivision.co.kr/wp-content/uploads/2022/01/main_con03_en.jpg

R&D
Network

http://umivision.co.kr/wp-content/uploads/2022/06/main_con05.jpg

R&D

UMI Optics has pioneered the field of ophthalmology based on its technology.

EYE DISEASEAntibacterial ABS Plug

EYE DISEASEMeibomian Gland

IV SETBaro Flush

PRODUCTS

Here are various products of UMI Optics sold in the global market.

http://umivision.co.kr/wp-content/uploads/2022/01/main_con12_en.jpg

I-VIEW100®

The I-VIEW100® is an AI-equipped automatic fundus camera that makes it easy for non-Ophthalmologists to take fundus shots and displays the risk of glaucoma, diabetic retinopathy, and macular degeneration within a second of fundus imaging.